MENU CATEGORIES

Connect with us

Submit a Tip
MENU CATEGORIES
Posts Tagged with "wafaa el-sadr"

Thursday was a big day for Low. First, it played shelter to Harry Potter-cum-Allen Ginsberg. Then just a few hours later, it hosted the University Lecture starring Wafaa El-Sadr, Director of the Global Health Initiative at Mailman School of Public Health here at Columbia. Her lecture entitled, “The HIV/AIDS Epidemic: Global Tragedy, Lasting Triumphs,” traced […]

Read More

Today, the MacArthur Foundation announced this year’s recipients of its famed Genius Grants, and one winner is the Mailman School’s own Wafaa El-Sadr. El-Sadr is a clinical researcher, specializing in such noble pursuits as studying alternative treatments for patients who can’t tolerate certain therapies and developing gels that inhibit HIV transmission. She is also chief […]

Read More

Same Semester, New President!

What Should Acting President Claire Shipman's Nickname Be?

View Results

Loading ... Loading ...

Recent Comments

This is the most beautiful graduation in the US. (read more)
Graduation WITH My Campus
March 4, 2026
this is beautiful, thank you for writing and sharing your strength!! (read more)
Navigating Anticipatory And Sudden Grief As A Columbia Student 
March 1, 2026
this is beautiful and so needed, so sorry for your lost......stay strong..... (read more)
Navigating Anticipatory And Sudden Grief As A Columbia Student 
February 27, 2026

Comment Policy

The purpose of Bwog’s comment section is to facilitate honest and open discussion between members of the Columbia community. We encourage commenters to take advantage of—without abusing—the opportunity to engage in anonymous critical dialogue with other community members. A comment may be moderated if it contains:
  • A slur—defined as a pejorative derogatory phrase—based on ethnicity, race, gender, sexual orientation, ability, or spiritual belief
  • Hate speech
  • Unauthorized use of a person’s identity
  • Personal information about an individual
  • Baseless personal attacks on specific individuals
  • Spam or self-promotion
  • Copyright infringement
  • Libel
  • COVID-19 misinformation